We found TMB and PD-L1 IHC scores were significantly lower in NTRK-positive head and neck tumors compared to NTRK-negative (1.1 vs. 5.4 mutations/Mb, 0 vs. 10 CPS, P < 0.03) (Figures 6A,B). Here, CD274 is linked to head and neck neoplasm.